Grupo de Investigación sobre Riesgo Cardiometabólico y Diabetes

Responsable de la Unidad de Investigación:

Áreas de investigación

Role of inflammatory axes in the modulation of metabolic and vascular dysfunctions in obesity, insulin resistance and diabetes
Primary dyslipidemias: molecular mechanisms, insulin resistance and novel therapeutic targets
Ageing, frailty, sarcopenia and neurodegeneration in people with diabetes
New diabetes technologies
Pharmacogenetic-based personalized treatment in diabetes
Applying Big Data and Artificial Intelligence technologies to analyse cardiovascular risk in dyslipidemia and diabetes
Adipokines, inflammatory axes, new therapeutic targets and cardiovascular risk in metabolic fatty liver disease
Body composition analysis - Effect of body composition analysis, vascular risk and treatment in people with diabetes - Impact of body composition analysis on prognosis, quality of life and therapeutic response in onco-haematological patients
Diabetes and its complications